Aurora Cannabis Urges Shareholders to Wait Amid Revised Curaleaf Bid
Aurora Cannabis has formally advised its shareholders to refrain from taking action regarding the revised hostile takeover bid from Curaleaf Holdings. The company’s board and a newly formed special committee have launched an independent review to determine if the offer, valued at approximately US$5.00 per share, represents true value.

























